vs
Cytek Biosciences, Inc.（CTKB）与McEwen Inc.（MUX）财务数据对比。点击上方公司名可切换其他公司
McEwen Inc.的季度营收约是Cytek Biosciences, Inc.的1.0倍（$64.6M vs $62.1M），McEwen Inc.净利率更高（59.0% vs -70.9%，领先129.9%），McEwen Inc.同比增速更快（92.8% vs 8.1%），过去两年McEwen Inc.的营收复合增速更高（25.2% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
McEwen Inc（股票代码MUX）是一家自然资源企业，主要从事金、银、铜矿产的勘探、开发与生产业务，运营项目分布于南北美洲，秉持可持续负责任的采矿准则，产品面向全球大宗商品市场供应。
CTKB vs MUX — 直观对比
营收规模更大
MUX
是对方的1.0倍
$62.1M
营收增速更快
MUX
高出84.7%
8.1%
净利率更高
MUX
高出129.9%
-70.9%
两年增速更快
MUX
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $64.6M |
| 净利润 | $-44.1M | $38.1M |
| 毛利率 | 52.9% | 26.9% |
| 营业利润率 | -9.0% | 34.2% |
| 净利率 | -70.9% | 59.0% |
| 营收同比 | 8.1% | 92.8% |
| 净利润同比 | -557.1% | 563.1% |
| 每股收益（稀释后） | — | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBMUX
| Q4 25 | $62.1M | $64.6M | ||
| Q3 25 | $52.3M | $50.5M | ||
| Q2 25 | $45.6M | $46.7M | ||
| Q1 25 | $41.5M | $35.7M | ||
| Q4 24 | $57.5M | $33.5M | ||
| Q3 24 | $51.5M | $52.3M | ||
| Q2 24 | $46.6M | $47.5M | ||
| Q1 24 | $44.9M | $41.2M |
净利润CTKBMUX
| Q4 25 | $-44.1M | $38.1M | ||
| Q3 25 | $-5.5M | $-462.0K | ||
| Q2 25 | $-5.6M | $3.0M | ||
| Q1 25 | $-11.4M | $-6.3M | ||
| Q4 24 | $9.6M | $-8.2M | ||
| Q3 24 | $941.0K | $-2.1M | ||
| Q2 24 | $-10.4M | $-13.0M | ||
| Q1 24 | $-6.2M | $-20.4M |
毛利率CTKBMUX
| Q4 25 | 52.9% | 26.9% | ||
| Q3 25 | 52.7% | 15.5% | ||
| Q2 25 | 52.3% | 26.3% | ||
| Q1 25 | 48.6% | 28.2% | ||
| Q4 24 | 58.5% | 1.1% | ||
| Q3 24 | 56.3% | 26.4% | ||
| Q2 24 | 54.6% | 22.7% | ||
| Q1 24 | 51.3% | 14.6% |
营业利润率CTKBMUX
| Q4 25 | -9.0% | 34.2% | ||
| Q3 25 | -17.6% | -16.7% | ||
| Q2 25 | -23.3% | -7.2% | ||
| Q1 25 | -36.1% | -21.4% | ||
| Q4 24 | 5.2% | -43.4% | ||
| Q3 24 | -8.2% | -0.2% | ||
| Q2 24 | -18.3% | -29.4% | ||
| Q1 24 | -23.9% | -53.3% |
净利率CTKBMUX
| Q4 25 | -70.9% | 59.0% | ||
| Q3 25 | -10.5% | -0.9% | ||
| Q2 25 | -12.2% | 6.5% | ||
| Q1 25 | -27.5% | -17.6% | ||
| Q4 24 | 16.8% | -24.6% | ||
| Q3 24 | 1.8% | -4.0% | ||
| Q2 24 | -22.4% | -27.4% | ||
| Q1 24 | -13.8% | -49.4% |
每股收益（稀释后）CTKBMUX
| Q4 25 | — | $0.66 | ||
| Q3 25 | — | $-0.01 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $72.1M |
| 总债务越低越好 | — | $126.2M |
| 股东权益账面价值 | $341.7M | $546.2M |
| 总资产 | $461.5M | $820.2M |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资CTKBMUX
| Q4 25 | $90.9M | $72.1M | ||
| Q3 25 | $93.3M | $75.4M | ||
| Q2 25 | $75.5M | $69.5M | ||
| Q1 25 | $95.3M | $79.3M | ||
| Q4 24 | $98.7M | $15.3M | ||
| Q3 24 | $162.3M | $30.2M | ||
| Q2 24 | $177.9M | $42.6M | ||
| Q1 24 | $168.8M | $22.0M |
总债务CTKBMUX
| Q4 25 | — | $126.2M | ||
| Q3 25 | — | $126.0M | ||
| Q2 25 | — | $125.8M | ||
| Q1 25 | — | $125.5M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $31.0M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | — | $37.0M |
股东权益CTKBMUX
| Q4 25 | $341.7M | $546.2M | ||
| Q3 25 | $378.6M | $488.6M | ||
| Q2 25 | $377.6M | $484.5M | ||
| Q1 25 | $379.6M | $479.8M | ||
| Q4 24 | $395.7M | $495.0M | ||
| Q3 24 | $385.5M | $502.1M | ||
| Q2 24 | $389.1M | $485.2M | ||
| Q1 24 | $392.6M | $482.5M |
总资产CTKBMUX
| Q4 25 | $461.5M | $820.2M | ||
| Q3 25 | $494.9M | $747.6M | ||
| Q2 25 | $493.3M | $735.6M | ||
| Q1 25 | $482.6M | $730.6M | ||
| Q4 24 | $499.5M | $664.6M | ||
| Q3 24 | $491.2M | $667.8M | ||
| Q2 24 | $483.7M | $645.1M | ||
| Q1 24 | $492.1M | $638.7M |
负债/权益比CTKBMUX
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | — | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $3.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBMUX
| Q4 25 | $-771.0K | $3.1M | ||
| Q3 25 | $-3.9M | $5.2M | ||
| Q2 25 | $108.0K | $478.0K | ||
| Q1 25 | $-125.0K | $-1.9M | ||
| Q4 24 | $2.0M | $-1.2M | ||
| Q3 24 | $13.2M | $23.2M | ||
| Q2 24 | $6.2M | $3.6M | ||
| Q1 24 | $4.0M | $3.9M |
自由现金流CTKBMUX
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
自由现金流率CTKBMUX
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度CTKBMUX
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
现金转化率CTKBMUX
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.16× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MUX
暂无分部数据
